29 /100
MEDIUM RISK
Score updated May 30, 2026

AKTS — Aktis Oncology, Inc. Dilution Risk Tracker

Track AKTS dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track AKTS — Get alerts when the score changes →

📊 Score Breakdown

📋 Offering Ability
40
💰 Cash Runway
0
📊 Float Risk
45
⚠️ Warrant Exposure
15
🔄Convertible Debt—

🌦️ Dilution Forecast

☀️
Clear
No significant dilution signals
0%
No significant dilution signals detected for AKTS.
🔔 Track AKTS — Get forecast alerts →

💹 Market Data

Market Cap$1.15B
Shares Outstanding53.40M
Float28.15M
Cash$538.48M
Debt$11.58M
Short InterestN/A

🏛 Institutional Holdings

QoQ: ↓ 94.2% shares (2025Q4 vs prior)
3 institutional holders · 28.8K shares
#1 Kohmann Bosshard Financial Services, LLC 27.8K shares
#2 Sarver Vrooman Wealth Advisors 1.0K shares
#3 VSM Wealth Advisory, LLC 50 shares

📉 Short Interest

Short Interest2.53M
Days to Cover16.7
% of Float9.0%
FINRA data as of May 15, 2026

📁 Recent SEC Activity

xbrl XBRL CONVERTIBLE Mar 31, 2026
4 INSIDER TRANSACTION Apr 16, 2026
3 FORM3 Apr 16, 2026
3 FORM3 Jan 15, 2026
4 INSIDER TRANSACTION Jan 14, 2026
Full SEC filing analysis available with free account →

📰 Recent News

No recent news
Track AKTS Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking AKTS — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required
Similar risk profiles: ADAG AIEV AIP ALLO ALOY
🔬 More Research for AKTS
📊 AKTS FDA Catalyst Timeline & Biotech Grade — BiotechSigns 📡 AKTS Signal Convergence & Dark Pool Activity — StonkWhisper

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.